Business Context and Reporting Period
Company: Omeros Corporation
Filing Type: Form 8-K (Current Report)
Date of Report: November 8, 2018
Reporting Period: The filing announces financial results for the three and nine months ended September 30, 2018.
Key Financial Metrics
The provided text serves as a cover report referencing a press release (Exhibit 99.1) for detailed figures. The filing text itself does not provide specific values for revenue, profit, cash flow, margins, debt, or liquidity.
Material Changes
The filing text does not contain specific data regarding material changes versus prior comparable periods. It only indicates that results for the specified periods were announced.
Guidance, Outlook, and Risks
Management Commentary: The filing incorporates by reference a press release containing the financial results but does not include the text of the commentary, guidance, or outlook within this document.
Risks and Contingencies: No specific risks or contingencies are detailed in the provided text.
Unusual Items: None identified in the provided text.
Investor Verification Checklist
- Review Exhibit 99.1 (Press Release dated November 8, 2018) for actual revenue, net loss, and cash position figures.
- Verify the specific drivers of financial performance for the three and nine months ended September 30, 2018.
- Check for any updated clinical trial data or regulatory milestones mentioned in the referenced press release.
- Confirm the company's cash runway and liquidity status as detailed in the full financial report.